AAAAAA
Results: 1-25/37
Authors:
DAHLOF C
DIENER HC
GOADSBY PJ
MASSIOU H
OLESEN J
SCHOENEN J
WILKINSON M
SWEET RM
KLEIN KB
Citation: C. Dahlof et al., ZOLMITRIPTAN, A 5-HT1B 1D RECEPTOR AGONIST FOR THE ACUTE ORAL TREATMENT OF MIGRAINE - A MULTICENTER, DOSE-RANGE FINDING STUDY/, European journal of neurology, 5(6), 1998, pp. 535-543
Authors:
DAHLOF C
HOGENHUIS L
OLESEN J
PETIT H
RIBBAT J
SCHOENEN J
BOSWELL D
FUSEAU E
HASSANI H
WINTER P
Citation: C. Dahlof et al., EARLY CLINICAL-EXPERIENCE WITH SUBCUTANEOUS NARATRIPTAN IN THE ACUTE TREATMENT OF MIGRAINE - A DOSE-RANGING STUDY, European journal of neurology, 5(5), 1998, pp. 469-477
Authors:
HARDEBO JE
DAHLOF C
Citation: Je. Hardebo et C. Dahlof, SUMATRIPTAN NASAL SPRAY (20 MG DOSE) IN THE ACUTE TREATMENT OF CLUSTER HEADACHE/, Cephalalgia, 18(7), 1998, pp. 487-489
Authors:
ADELMAN JU
BAUMEL B
CADY RK
BAKER CC
COUCH JR
DALESSIO DJ
DIAMOND S
ELKIND AH
FOSTER CA
GOLDSTEIN J
KATZ DA
KIRCHNER JR
KLAPPER JA
KUDROW DB
KUNKEL R
LANDY SH
LICHT JM
LINDER SL
LODER E
MARKLEY HG
MATHEW NT
MEYER JS
NETT R
PACKARD RC
PERSE T
PETERS KS
RAMADAN NM
RAPOPORT AM
ROSING HS
SADOWSKY C
SAPER JR
SHARFMAN MI
SILBERSTEIN SD
SINGER RP
SMITH R
SOLOMON G
SOLOMON S
STARK SR
SWANSON JW
TAYLOR FR
TEPPER SJ
TUCHMAN MM
VIJAYAN N
WALKER J
WARD T
WARNER JS
WENDT JK
WINNER P
BERAN P
BLACK A
DONNAN G
HERKES G
LORD G
ZAGAMI A
BAUMHACKL U
BROUSSALIS T
KLINGLER D
LADURNER G
JACQUY J
LOUIS P
SCHOENEN J
GAWEL MJ
HANSEN PE
JENSEN K
PEDERSEN KK
KORSGAARD A
LADEMANN A
OLESEN J
SIMONSEN N
SORENSEN PS
JENSEN TS
TFELTHANSEN P
KAASIK AE
ZUPPING R
FARKKILA M
HAANPAA M
HAVANKA H
HEDMAN C
ILMAVIRTA M
KINNUNEN E
LIUKKONEN J
PARTINEN M
RAUTAKORPI I
REUNANEN M
SAKO E
SEPPA JM
BAREGE M
CHAZOT G
COLOMBANI JP
DUJARDIN M
FABRE N
GIACOMINO A
GERAUD G
HENRY P",JOGEIX,"LAPORTE A",LICHTBLAU,"MASSIOU H",MAZINGUEDESAILLY,"MIHOUT B
PETIT H
VEYRIE M
VILAREM H
WILMANN JF
BECKMANNREINHOLDT A
DIENER HC
EVERS S
GOBEL H
KLEPEL H
KUHL W
LANGOHR HD
NEU I
PAULUS W
PEIKERT A
PFAFFENRATH V
SCHOLZ E
STRAUBE A
WITTE OW
HARMOUSI S
KARAGEORGIOU C
MILONAS I
GIACOVAZZO M
NAPPI G
TERBERG JWM
SANDERS EACM
VANDERZWAN JL
EDLAND A
ENGELSEN B
GRONNING M
HALDORSEN T
HODNEBO A
LARSEN JP
DORNZAL T
PRUSINSKI A
SZCZUDLIK A
NAYA MG
GRANELL AN
LAINEZ JM
LEIRA R
LIANO H
PASCUAL J
BOIVIE J
DAHLOF C
EDVINSSON L
HARDEBO JE
NILSSON H
WALDENLIND E
ISLER HR
CRAWFORD P
DOWSON AJ
FINDLEY L
GROSS M
HAWKES CH
JESTICO J
ROLAN P
STEINER TJ
WILKINSON M
WAGNER G
Citation: Ju. Adelman et al., THE LONG-TERM TOLERABILITY AND EFFICACY OF ORAL ZOLMITRIPTAN (ZOMIG, 311C90) IN THE ACUTE TREATMENT OF MIGRAINE - AN INTERNATIONAL STUDY, Headache, 38(3), 1998, pp. 173-183
Authors:
HEYWOOD J
BOUCHARD J
CORTELLI P
DAHLOF C
JANSEN JP
PHAM S
HIRSCH J
EDWARDS CE
ADAMS J
BERTO P
BRUEGGENJUERGEN B
NYTH AL
LINDSAY P
PRICE KL
Citation: J. Heywood et al., A MULTINATIONAL INVESTIGATION OF THE IMPACT OF SUBCUTANEOUS SUMATRIPTAN .1. DESIGN, METHODS AND CLINICAL FINDINGS, PharmacoEconomics, 11, 1997, pp. 11-23
Authors:
DAHLOF C
BOUCHARD J
CORTELLI P
HEYWOOD J
JANSEN JP
PHAM S
HIRSCH J
ADAMS J
MILLER DW
Citation: C. Dahlof et al., A MULTINATIONAL INVESTIGATION OF THE IMPACT OF SUBCUTANEOUS SUMATRIPTAN .2. HEALTH-RELATED QUALITY-OF-LIFE, PharmacoEconomics, 11, 1997, pp. 24-34
Authors:
CORTELLI P
DAHLOF C
BOUCHARD J
HEYWOOD J
JANSEN JP
PHAM S
HIRSCH J
ADAMS J
MILLER DW
Citation: P. Cortelli et al., A MULTINATIONAL INVESTIGATION OF THE IMPACT OF SUBCUTANEOUS SUMATRIPTAN .3. WORKPLACE PRODUCTIVITY AND NON-WORKPLACE ACTIVITY, PharmacoEconomics, 11, 1997, pp. 35-42
Authors:
BOUCHARD J
CORTELLI P
DAHLOF C
HEYWOOD J
JANSEN JP
PRICE KL
PHAM S
JOSEPH A
BABIAK L
Citation: J. Bouchard et al., A MULTINATIONAL INVESTIGATION OF THE IMPACT OF SUBCUTANEOUS SUMATRIPTAN .4. PATIENT SATISFACTION, PharmacoEconomics, 11, 1997, pp. 43-50
Authors:
DAHLOF C
FERRARI M
SCHOENEN J
EDMEADS J
GOADSBY P
MASSIOU H
Citation: C. Dahlof et al., FROM GENETICS TO PROPHYLAXIS - DISCUSSION, Cephalalgia, 17, 1997, pp. 4-5
Authors:
MASSIOU H
TFELTHANSEN P
GOADSBY P
FERRARI M
EDMEADS J
DAHLOF C
SCHOENEN J
Citation: H. Massiou et al., HOW TO DEFINE THE BEST EFFICACY PARAMETERS FOR MIGRAINE - DISCUSSION, Cephalalgia, 17, 1997, pp. 8-9
Authors:
FERRARI M
GOADSBY P
SCHOENEN J
DAHLOF C
EDMEADS J
Citation: M. Ferrari et al., IS A CENTRAL ACTION OF ACUTE ANTIMIGRAINE DRUGS ESSENTIAL - DISCUSSION, Cephalalgia, 17, 1997, pp. 11-11
Authors:
TFELTHANSEN P
SCHOENEN J
EDMEADS J
DAHLOF C
FERRARI M
GOADSBY P
Citation: P. Tfelthansen et al., MEASURING CENTRAL ACTION OF ACUTE ANTIMIGRAINE DRUGS IN HUMANS - DISCUSSION, Cephalalgia, 17, 1997, pp. 15-16
Authors:
DAHLOF C
Citation: C. Dahlof, WOULD ANY ACUTE TREATMENT FOR MIGRAINE DEMONSTRATE RECURRENCE, Cephalalgia, 17, 1997, pp. 17-19
Authors:
TFELTHANSEN P
FERRARI M
GOADSBY P
DAHLOF C
MASSIOU H
Citation: P. Tfelthansen et al., WOULD ANY ACUTE TREATMENT FOR MIGRAINE DEMONSTRATE RECURRENCE - DISCUSSION, Cephalalgia, 17, 1997, pp. 19-20
Authors:
EDMEADS J
ANTONACI F
GOADSBY P
FERRARI M
DAHLOF C
TFELTHANSEN P
Citation: J. Edmeads et al., WHAT IS THE ROLE OF INTERNATIONAL SOCIETIES AND WHAT COULD THEY DO BETTER - DISCUSSION, Cephalalgia, 17, 1997, pp. 27-28
Authors:
NEDERFORS T
ISAKSSON R
MORNSTAD H
DAHLOF C
Citation: T. Nederfors et al., PREVALENCE OF PERCEIVED SYMPTOMS OF DRY MOUTH IN AN ADULT SWEDISH POPULATION - RELATION TO AGE, SEX AND PHARMACOTHERAPY, Community dentistry and oral epidemiology, 25(3), 1997, pp. 211-216
Authors:
DAHLOF C
WINTER P
WHITEHOUSE H
HASSANI H
Citation: C. Dahlof et al., RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED COMPARISON OF ORAL NARATRIPTAN AND ORAL SUMATRIPTAN IN THE ACUTE TREATMENT OF MIGRAINE, Neurology, 48(3), 1997, pp. 8003-8003
Authors:
NEDERFORS T
DAHLOF C
Citation: T. Nederfors et C. Dahlof, EFFECTS ON SALIVARY FLOW-RATE AND COMPOSITION OF WITHDRAWAL OF AND REEXPOSURE TO THE BETA(1)-SELECTIVE ANTAGONIST METOPROLOL IN A HYPERTENSIVE PATIENT POPULATION, European journal of oral sciences, 104(3), 1996, pp. 262-268
Authors:
AGEWALL S
WIKSTRAND J
DAHLOF C
FAGERBERG B
Citation: S. Agewall et al., NEGATIVE FEELINGS (DISCONTENT) PREDICT PROGRESS OF INTIMA-MEDIA THICKNESS OF THE COMMON CAROTID-ARTERY IN TREATED HYPERTENSIVE MEN AT HIGH CARDIOVASCULAR RISK, American journal of hypertension, 9(6), 1996, pp. 545-550
Authors:
NEDERFORS T
DAHLOF C
Citation: T. Nederfors et C. Dahlof, EFFECTS ON SALIVARY FLOW-RATE AND COMPOSITION OF WITHDRAWAL OF AND REEXPOSURE TO THE BETA(1)-SELECTIVE ANTAGONIST METOPROLOL IN A HYPERTENSIVE PATIENT POPULATION, Journal of dental research, 75, 1996, pp. 2853-2853
Authors:
HELLENIUS ML
DAHLOF C
ABERG H
KRAKAU I
DEFAIRE U
Citation: Ml. Hellenius et al., QUALITY-OF-LIFE IS NOT NEGATIVELY AFFECTED BY DIET AND EXERCISE INTERVENTION IN HEALTHY-MEN WITH CARDIOVASCULAR RISK-FACTORS, Quality of life research, 4(1), 1995, pp. 13-20
Authors:
NEDERFORS T
DAHLOF C
ERICSSON T
TWETMAN S
Citation: T. Nederfors et al., EFFECTS OF THE ANTIHYPERTENSIVE DRUG CAPTOPRIL ON HUMAN SALIVARY SECRETION RATE AND COMPOSITION, European journal of oral sciences, 103(6), 1995, pp. 351-354
Authors:
AGEWALL S
WIKSTRAND J
DAHLOF C
FAGERBERG B
Citation: S. Agewall et al., A RANDOMIZED STUDY OF QUALITY-OF-LIFE DURING MULTIPLE RISK FACTOR INTERVENTION IN TREATED HYPERTENSIVE MEN AT HIGH CARDIOVASCULAR RISK, Journal of hypertension, 13(12), 1995, pp. 1471-1477
Authors:
DAHLOF C
DIMENAS E
Citation: C. Dahlof et E. Dimenas, MIGRAINE PATIENTS EXPERIENCE POORER SUBJECTIVE WELL-BEING QUALITY OF LIFE EVEN BETWEEN ATTACKS/, Quality of life research, 3(1), 1994, pp. 72-72
Authors:
SALONEN R
ASHFORD E
DAHLOF C
DAWSON R
GILHUS NE
LUBEN V
NORONHA D
WARTER JM
Citation: R. Salonen et al., INTRANASAL SUMATRIPTAN FOR THE ACUTE TREATMENT OF MIGRAINE, Journal of neurology, 241(8), 1994, pp. 463-469